Email Updates

You are here

AVAC in the News

  • AIDS denialism — the government’s refusal to acknowledge HIV as the cause of AIDS, and as a result provide people with HIV with lifesaving antiretroviral (ARV) treatment — may have cost at least a third of a million South Africans their lives. That’s how many people would likely not have died of AIDS, had they had access to treatment. Now lobbyists pushing for vaping as a way to help people quit smoking insist taxing e-cigarettes like traditional smokes is leading down a similar path.

    March 22, 2022
    Bhekisisa
  • If you bring your index finger to your thumb then make a circle, that’s about how small this silicone ring is. Its size is tiny but its impact enormous, which is why SAHPRA’s decision to give South Africa the regulatory go-ahead to make the dapivirine vaginal ring (DVR) available monthly to women 18 and older has been lauded by women’s health and reproductive rights advocates as seismic.

    March 18, 2022
    News24
  • South African women who are at risk of HIV infection will now have more options for protecting themselves against infection after the approval of a vaginal ring by the country’s regulator.

    March 16, 2022
    Times Live
  • SA’s medicines regulator has approved a vaginal ring that slowly releases the drug dapirivine, offering women protection from HIV for up to a month at a time. The development has been hailed by HIV advocates as a milestone in the quest to provide women with more options for reducing their risk of contracting the virus, but it is not clear when it will be available in SA.

    March 14, 2022
    Business Day
  • The effectiveness of pre-exposure prophylaxis (PrEP) is well known but its availability has reached a turning point. Access to PrEP, previously solely targeted at men who have sex with men, is now being offered to women, primarily in Western countries. Some pioneering African countries are now offering PrEP to female sex workers, transgender people and the sexual partners of people who inject drugs. Three organizations in Mali, Mauritius and Morocco have developed a community project offering PrEP to HIV-exposed women. It provides women with tailored, sustainable services, combining research, advocacy and implementation. It shows real promise of success and has potential for scale up and replication.

    March 11, 2022
    AIDSpan
  • Every year, a few young minds from different parts of the world aspire to work at the grassroots to understand and mitigate advocacy and research problems towards an HIV cure. These are made possible jointly through the International AIDS Society (Int. AIDS Society) Towards an HIV cure initiative and AVAC awarding fellowship to talented advocates who are working in the HIV field in resource-limited settings and who are interested in HIV care-related advocacy.

    March 10, 2022
    Medium
  • Worldwide deaths from COVID-19 surpassed 6 million on Monday, a grim reminder of the coronavirus’s lethality as many countries relax mask-wearing and vaccination requirements.

    March 7, 2022
    General
    Washington Post
  • When given a choice of two proven HIV pre-exposure prophylaxis (PrEP) options, young cisgender women will use both but prefer a monthly vaginal ring, according to data presented at the Conference on Retroviruses and Opportunistic Infections 2022 (CROI 2022).

    March 4, 2022
    POZ
  • Rolling out a new HIV prevention injection should be a priority in South Africa, says Thandi Maluka, Executive Director of HIV activist group Positive Women’s Network (PWN). She says an HIV prevention injection, administered every two months, is going to make life easier for many people, especially young people. This is because the injection can be taken more discreetly than prevention pills.

    March 3, 2022
    Health 24
  • When given the option, adolescent girls and young women in Africa overwhelmingly opted to use either a drug-eluting vaginal ring or oral pre-exposure prophylaxis (PrEP) to protect against HIV infection, a researcher reported.

    February 18, 2022
    MedPage Today

Pages